Heterotopic Ossification (HO)
Also known as: Ossification, Heterotopic / Heterotopic Ossification / Heterotopic ossification (finding) / Ectopic ossification / Extraskeletal ossification / Osseous metaplasia (morphologic abnormality, calcified structure) (morphologic abnormality) / Osteosis
Drug | Drug Name | Drug Description |
---|---|---|
DB01077 | Etidronic acid | A bisphosphonate drug that prevents osteoclastic bone resorption; used for the prevention and treatment of osteoporosis. |
DB05467 | Palovarotene | A selective agonist of retinoic acid receptor gamma (RARĪ³) used to reduce heterotopic ossification in patients with Fibrodysplasia Ossificans Progressiva (FOP). |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00788 | Naproxen | 0 | Completed | 1 |
DB16379 | Garetosmab | 3 | Withdrawn | 1 |
DB01628 | Etoricoxib | 4 | Completed | 1 |
DB00788 | Naproxen | 4 | Withdrawn | 1 |
DB00482 | Celecoxib | Not Available | Unknown Status | 1 |
DB00586 | Diclofenac | Not Available | Completed | 1 |
DB00282 | Pamidronic acid | Not Available | Withdrawn | 1 |
DB00302 | Tranexamic acid | Not Available | Completed | 1 |